Literature DB >> 29936472

Novel Potential Biomarkers for Opisthorchis viverrini Infection and Associated Cholangiocarcinoma.

Nithikoon Aksorn1,2, Sittiruk Roytrakul3, Suthathip Kittisenachai3, Kawin Leelawat4, Pithi Chanvorachote5, Supachai Topanurak6, Shinjiro Hamano7, Usa Lek-Uthai8.   

Abstract

BACKGROUND/AIM: Early detection of disease is a pivotal factor for determining prognosis and clinical outcome of patients with cancer. As cholangiocarcinoma (CCA) is currently difficult to detect and most cases of such cancer present with late-stage disease at the time of initial diagnosis, we employed proteomic analysis of the bile to identify potential candidate biomarkers for Opisthorchis viverrini (OV)-associated CCA.
MATERIALS AND METHODS: Proteins in pooled bile samples from patients with CCA and OV infection, with CCA without OV infection, with OV infection but no CCA, and with neither OV infection nor CCA were separated by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, in-gel trypsin digestion and analyzed by liquid chromatography-tandem mass spectrometry.
RESULTS: According to our analysis, three proteins, namely aristaless-like homeobox1 isoform X1 (ALX1), major histocompatibility complex polypeptide-related sequence A (MICA), and uncharacterized protein C14orf105 isoform X12 were found to be potential markers for OV infection, as they were predominantly found in all OV-infected groups. Although these proteins were detected in both OV-infected patients with and without CCA, their abundance was 2.90-, 7.06-and 3.65-fold higher, respectively, in those with CCA. In patients with CCA, potential novel biomarkers wre immunoglobulin heavy chain, translocated in liposarcoma (TLS), visual system homeobox 2 (VSX2) and an unnamed protein product.
CONCLUSION: We provided novel information regarding potential biomarkers for OV infection and CCA. These two protein profiles could benefit diagnosis as well as monitoring of CCA. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Opisthorchis viverrini; bile; biomarkers; cholangiocarcinoma; proteomics

Mesh:

Substances:

Year:  2018        PMID: 29936472      PMCID: PMC6117776          DOI: 10.21873/invivo.11321

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  47 in total

Review 1.  Proteomics in early detection of cancer.

Authors:  P R Srinivas; S Srivastava; S Hanash; G L Wright
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Depletion of ALX1 causes inhibition of migration and induction of apoptosis in human osteosarcoma.

Authors:  Mingfu Yang; Yong Pan; Yue Zhou
Journal:  Tumour Biol       Date:  2015-03-04

4.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 5.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

Review 6.  Review of endoscopic techniques in the diagnosis and management of cholangiocarcinoma.

Authors:  Katherine Nguyen; James-T Sing
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

7.  Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma.

Authors:  Rucksak Rucksaken; Jarinya Khoontawad; Sittiruk Roytrakul; Porntip Pinlaor; Yusuke Hiraku; Chaisiri Wongkham; Chawalit Pairojkul; Thidarut Boonmars; Somchai Pinlaor
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

8.  Chemotherapy for cholangiocarcinoma: An update.

Authors:  Natalia Ramírez-Merino; Santiago Ponce Aix; Hernán Cortés-Funes
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

Review 9.  Proteomic analysis of human bile and potential applications for cancer diagnosis.

Authors:  Annarita Farina; Jean-Marc Dumonceau; Pierre Lescuyer
Journal:  Expert Rev Proteomics       Date:  2009-06       Impact factor: 3.940

Review 10.  Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations.

Authors:  Saurabh Yadav; Navonil DE Sarkar; Niraj Kumari; Narendra Krishnani; Ashok Kumar; Balraj Mittal
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

View more
  3 in total

Review 1.  Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

Authors:  Fang Bao; Jiayue Liu; Haiyang Chen; Lu Miao; Zhaochao Xu; Guixin Zhang
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

Review 2.  Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma.

Authors:  Yu-Chan Chang; Ming-Huang Chen; Chun-Nan Yeh; Michael Hsiao
Journal:  Biomolecules       Date:  2020-09-28

3.  Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma.

Authors:  Hao Liang; Mingxing Xu; Zhiyong Xiong; Kunpeng Hu; Jiarui Yang; Mingbo Cao; Zhaozhong Zhong; Zhicheng Yao; Meihai Deng; Bo Liu
Journal:  Aging (Albany NY)       Date:  2021-02-22       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.